Company

Ping An Biomedical Signs LOI To Acquire Three Oncology Technology Patents For $2M-$2.5M

Oct 22, 2026 · 03:32 PM ET· updated 1h ago

Ping An Biomedical Co., Ltd. (NASDAQ:PASW) (the "Company") today announced its entry into a letter of intent with Future Biotechnology Group Co., Limited (the "Letter of Intent"), for the planned

Why It Matters

Ping An Biomedical wants to buy cancer treatment patents for two to two point five million dollars. This shows the company is spending money to grow its medicine business and fight cancer.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

PASW0.10

+0.01 (+9.89%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.